PGFC
EW icon

Peapack-Gladstone Financial Corp’s Edwards Lifesciences EW Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18M Sell
225,165
-36,251
-14% -$2.99M 0.23% 107
2025
Q4 		$22.3M Sell
261,416
-8,244
-3% -$677K 0.28% 91
2025
Q3 		$21M Buy
269,660
+4,272
+2% +$334K 0.27% 94
2025
Q2 		$20.8M Sell
265,388
-4,676
-2% -$349K 0.29% 92
2025
Q1 		$19.6M Sell
270,064
-18,386
-6% -$1.32M 0.29% 89
2024
Q4 		$21.4M Sell
288,450
-5,308
-2% -$372K 0.31% 88
2024
Q3 		$19.4M Buy
293,758
+152,539
+108% +$11.1M 0.28% 94
2024
Q2 		$13M Buy
141,219
+7,018
+5% +$621K 0.2% 121
2024
Q1 		$12.8M Buy
134,201
+33,763
+34% +$2.84M 0.2% 123
2023
Q4 		$7.66M Buy
100,438
+10,232
+11% +$712K 0.13% 170
2023
Q3 		$6.25M Sell
90,206
-7,453
-8% -$599K 0.12% 175
2023
Q2 		$9.21M Buy
97,659
+13,483
+16% +$1.17M 0.16% 150
2023
Q1 		$6.96M Sell
84,176
-21,027
-20% -$1.65M 0.13% 173
2022
Q4 		$7.85M Buy
105,203
+38,222
+57% +$2.95M 0.15% 154
2022
Q3 		$5.53M Buy
66,981
+10,454
+18% +$1.01M 0.11% 185
2022
Q2 		$5.38M Buy
56,527
+31,226
+123% +$3.23M 0.12% 169
2022
Q1 		$2.98M Buy
25,301
+4,261
+20% +$478K 0.06% 241
2021
Q4 		$2.73M Buy
21,040
+2,314
+12% +$270K 0.05% 252
2021
Q3 		$2.12M Buy
18,726
+2,892
+18% +$330K 0.04% 273
2021
Q2 		$1.64M Buy
15,834
+5,158
+48% +$486K 0.04% 271
2021
Q1 		$893K Sell
10,676
-17,336
-62% -$1.47M 0.02% 336
2020
Q4 		$2.56M Sell
28,012
-545
-2% -$45.2K 0.08% 187
2020
Q3 		$2.28M Buy
28,557
+21,954
+332% +$1.71M 0.08% 169
2020
Q2 		$456K Sell
6,603
-75
-1% -$5.33K 0.02% 282
2020
Q1 		$420K Buy
6,678
+450
+7% +$32.5K 0.02% 277
2019
Q4 		$484K Sell
6,228
-159
-2% -$12.4K 0.02% 259
2019
Q3 		$468K Sell
6,387
-450
-7% -$31.6K 0.02% 260
2019
Q2 		$421K Buy
6,837
+3,483
+104% +$211K 0.02% 265
2019
Q1 		$214K Buy
+3,354
New +$191K 0.01% 327

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Peapack-Gladstone Financial Corp's EW Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp reduced its Edwards Lifesciences (EW) stake by 14% in Q1 2026, selling an estimated $2.99M and leaving 225,165 shares worth $18M. The position accounts for 0.23% of the portfolio, ranked #107.

Peapack-Gladstone Financial Corp first reported a position in EW in Q1 2019 and has held it in 29 quarters since. The position peaked at $22.3M in Q4 2025. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Peapack-Gladstone Financial Corp held 225,165 shares of Edwards Lifesciences worth $18M as of Q1 2026.
  • Peapack-Gladstone Financial Corp sold 36,251 Edwards Lifesciences shares in Q1 2026, an estimated $2.99M.
  • Edwards Lifesciences made up 0.23% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #107 holding.
  • Peapack-Gladstone Financial Corp first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 29 quarters since.
  • Peapack-Gladstone Financial Corp's Edwards Lifesciences position peaked at $22.3M in Q4 2025.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.